Bandingkan Harga & Kinerja Ciputra Development Tbk (CTRA) vs Dharma Polimetal Tbk. (DRMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ciputra Development Tbk dan Dharma Polimetal Tbk.: Ciputra Development Tbk diperdagangkan di Rp560 (kapitalisasi pasar 10,29 T, volume 24 jam 11,27 jt), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp930 (kapitalisasi pasar 4,35 T, volume 24 jam 825,7 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 2,4× kapitalisasi pasar Dharma Polimetal Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (11,27 jt vs 825,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | DRMA | |
|---|---|---|
Kapitalisasi Pasar | 10,29 T | 4,35 T |
Volume | 11,27 jt | 825,7 rb |
Lot | 112,75 rb | 8,26 rb |
Perputaran | 6,32 M | 768,05 jt |
Harga Rata-rata | 560,45 | 930,18 |
Nilai Transaksi | 6,32 M | 768,05 jt |
Harga Ekuilibrium Indikatif | 560 | 930 |
Volume Ekuilibrium Indikatif | 3,05 rb | 2 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ciputra Development Tbk
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →Tentang Dharma Polimetal Tbk.
PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Selengkapnya di halaman DRMA →
